Skip to main content

Table 1 Numerical values for Figs. 1 and 2

From: The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization

ERH

Sample Size

Avg. M II ± SD

Avg. MR ± SD

Avg. FE ± SD

Avg. FR ± SD

Avg. Embryo ± SD

Avg. CR ± SD

Avg. HQ Embryo ± SD

Avg. HQER ± SD

Outcome

35

509

6.1 ± 4.8

.63 ± .21

4.0 ± 3.5

.54 ± .28

3.2 ± 1.9

.82 ± .3

1.7 ± 1.4

.57 ± .31

.33

36

1653

7.2 ± 5.0

.60 ± .19

5.0 ± 3.7

.56 ± .24

3.7 ± 1.9

.8 ± .29

1.9 ± 1.4

.55 ± .29

.38

37

1072

8.3 ± 5.5

.61 ± .18

5.7 ± 4.1

.55 ± .24

4.1 ± 1.9

.75 ± .3

2.0 ± 1.5

.52 ± .29

.41

38

128

8.8 ± 5.1

.61 ± .18

6.1 ± 4.0

.56 ± .25

4.3 ± 1.9

.69 ± .34

2.2 ± 1.6

.52 ± .31

.38

  1. Note. Uneven distribution of the samples among the groups of ERHs. FR fertilization rate, MR maturation rate, SD Standard Deviation, Outcome = Clinical Pregnancy Occurrence Positive Percentage, CR Cleavage Rate, HQER High Quality Embryo Rate